Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katie Hudson"'
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Programmed death-ligand 1 (PD-L1) is an immune checkpoint inhibitor that binds to its receptor PD-1 expressed by T cells and other immune cells to regulate immune responses; ultimately preventing exacerbated activation and autoimmunity. Many tumors e
Externí odkaz:
https://doaj.org/article/f65c4066da144be3989cafa99f077a9e
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Programmed death-ligand 1 (PD-L1) is an immune checkpoint inhibitor that binds to its receptor PD-1 expressed by T cells and other immune cells to regulate immune responses; ultimately preventing exacerbated activation and autoimmunity. Many tumors e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b448943924bcba51f6f74ba153a9e21f
https://shura.shu.ac.uk/27486/9/Leyland-ExtrinsicIntrinsicRoles(VoR).pdf
https://shura.shu.ac.uk/27486/9/Leyland-ExtrinsicIntrinsicRoles(VoR).pdf
Publikováno v:
Cancer Research. 81:2988-2988
Tumorigenic expression of programmed death-ligand 1 (PD-L1) and its receptor PD-1 is found in many cancers, though the intrinsic roles of these proteins and how immunotherapy treatment may affect these pathways needs to be fully explored across human
Autor:
Jennifer M. Down, Holly Evans, Michelle A. Lawson, Gwendolen C. Reilly, Julia Paton-Hough, Darren Lath, Katie Hudson, Robert Owen, Andrew D Chantry, Alanna C. Green, Brant Walkley
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchReferences. 34(12)
Multiple myeloma is a plasma cell malignancy that causes debilitating bone disease and fractures, in which TGFβ plays a central role. Current treatments do not repair existing damage and fractures remain a common occurrence. We developed a novel low
Autor:
Jolie Blankenship, Katie Hudson, Luke G. Wolfe, James W. Maher, John M. Kellum, Jill G. Meador
Publikováno v:
Surgery for Obesity and Related Diseases. 2:350-351